Literature DB >> 16168897

Neutrophils in human myocardial infarction with rupture of the free wall.

Nina Zidar1, Jera Jeruc, Joze Balazic, Dusan Stajer.   

Abstract

INTRODUCTION: Experimental studies have shown that neutrophils might play an important role in the pathogenesis of ischemic and reperfusion injury in myocardial infarction (MI). Our aim was to compare histologic characteristics of MI with and without rupture of the free wall (RFW), with emphasis on the density of interstitial neutrophil infiltration.
METHODS: Autopsy samples of infarcted heart tissue from 110 patients with MI (50 with and 60 without RFW) were included. On the basis of histologic changes and clinical data, all cases were divided into three groups according to the duration of MI (<or=1 day, 1--7 days, and 1--4 weeks). Neutrophils were stained immunohistochemically with antibodies against CD 15. The intensity of interstitial neutrophil infiltration was determined on the basis of percentage of the infiltrated myocardial area using an image analysis system.
RESULTS: In MI that were less than 1 day or more than 7 days old, we did not observe any differences in histologic characteristics between cases with and those without RFW. In MI that were more than 1 day and less than 7 days old, we observed a significantly more intensive interstitial neutrophil infiltration in cases with RFW than in those without RFW. However, there were no significant differences in neutrophil infiltration between patients who received reperfusion treatment and those who did not.
CONCLUSIONS: Our results suggest that intensive interstitial neutrophil infiltration in human MI might increase the risk of the RFW between the 2nd and the 7th days when the density of neutrophil infiltration is believed to reach a peak. We failed to confirm the hypothesis based on experimental studies that reperfusion treatment contributes significantly to the density of neutrophil infiltration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168897     DOI: 10.1016/j.carpath.2005.04.002

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  8 in total

1.  Immunohistochemical expression of activated caspase-3 in human myocardial infarction.

Authors:  Nina Zidar; Zvezdana Dolenc-Strazar; Jera Jeruc; Dusan Stajer
Journal:  Virchows Arch       Date:  2005-10-05       Impact factor: 4.064

2.  MicroRNA values in children with rheumatic carditis: a preliminary study.

Authors:  Gokhan Gumus; Dilek Giray; Onur Bobusoglu; Lulufer Tamer; Derya Karpuz; Olgu Hallioglu
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

3.  Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart.

Authors:  Holger Lörchner; Jochen Pöling; Praveen Gajawada; Yunlong Hou; Viktoria Polyakova; Sawa Kostin; Juan M Adrian-Segarra; Thomas Boettger; Astrid Wietelmann; Henning Warnecke; Manfred Richter; Thomas Kubin; Thomas Braun
Journal:  Nat Med       Date:  2015-03-09       Impact factor: 53.440

4.  Polymorphonuclear neutrophils promote endothelial apoptosis by enhancing adhesion upon stimulation by intermittent hypoxia.

Authors:  Jinna Li; Le Wang; Jie Hu; Xing Chen; Wei Zhou; Shuo Li; Hengjuan Guo; Yan Wang; Baoyuan Chen; Jing Zhang; Jie Cao
Journal:  Sleep Breath       Date:  2021-10-11       Impact factor: 2.655

5.  Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53.

Authors:  Baihe Chen; Di Lu; Yujuan Fu; Jingwen Zhang; Xiaobo Huang; Shiping Cao; Dingli Xu; Jianping Bin; Masafumi Kitakaze; Qiaobing Huang; Yulin Liao
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 6.  Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction.

Authors:  Mira Jung; Michael Dodsworth; Thomas Thum
Journal:  Basic Res Cardiol       Date:  2018-12-06       Impact factor: 17.165

7.  Hypoxia Promotes Neutrophil Survival After Acute Myocardial Infarction.

Authors:  Maximilian Dölling; Markus Eckstein; Jeeshan Singh; Christine Schauer; Janina Schoen; Xiaomei Shan; Aline Bozec; Jasmin Knopf; Georg Schett; Luis E Muñoz; Martin Herrmann
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

8.  Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation.

Authors:  Christina Pachel; Denise Mathes; Barbara Bayer; Charlotte Dienesch; Gaby Wangorsch; Wolfram Heitzmann; Isabell Lang; Hossein Ardehali; Georg Ertl; Thomas Dandekar; Harald Wajant; Stefan Frantz
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.